The National Coalition for LGBTQ Health has launched the “mfax” education and awareness campaign to raise awareness and provide education about mpox prevention, vaccination, testing, and treatment, as well as foster LGBTQ community engagement.
Two vaccines can be used to prevent mpox: JYNNEOS® and ACAM2000®, but only JYNNEOS has been used in the ongoing clade II outbreak. Healthcare providers should evaluate and counsel patients who could benefit from mpox vaccination by performing a social and sexual history.
Archived update from the White House from December 2024. During the 2022 global outbreak of clade II mpox, the Biden-Harris Administration mounted a robust response by making vaccines, tests, and treatment available to those at risk in the United States and abroad.
Study highlights need for defined markers of mpox immunity to inform public health use.
Study highlights need for defined markers of mpox immunity to inform public health use.
This information page from the CDC provides a checklist of factors for those seeking mpox vaccination. Includes a vaccination location finder.
JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S.